Nomura Securities Maintains a 'Neutral' on NVIDIA (NVDA); F3Q Review
Tweet
Share
E-mailGet Alerts NVDA Hot Sheet
Price: $225.01 -0.07%
Rating Summary:
58 Buy, 10 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 2 | Down: 6 | New: 5
Rating Summary:
58 Buy, 10 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 2 | Down: 6 | New: 5
Join SI Premium – FREE
Nomura Securities maintains a 'Neutral' on NVIDIA (NASDAQ: NVDA) price target raised $1 to $16.
Nomura analyst, Romit Shah, said, "Though maintaining a Neutral rating at present, we believe the bear case on Nvidia is weakening. The company executed well in a tough environment. Desktop, gaming, and professional graphics offset a widely expected decline in notebook graphics, and despite share loss and a product cycle transition in mobile, Tegra sales are holding firm in the January quarter. We aim to monitor sell-through of recent designs as well as overall PC end demand in the coming period. Overall, our estimates increase from $1.10 to $1.15 for FY13 and our price target moves to $16."
For an analyst ratings summary and ratings history on NVIDIA click here. For more ratings news on NVIDIA click here.
Shares of NVIDIA closed at $14.47 yesterday.
Nomura analyst, Romit Shah, said, "Though maintaining a Neutral rating at present, we believe the bear case on Nvidia is weakening. The company executed well in a tough environment. Desktop, gaming, and professional graphics offset a widely expected decline in notebook graphics, and despite share loss and a product cycle transition in mobile, Tegra sales are holding firm in the January quarter. We aim to monitor sell-through of recent designs as well as overall PC end demand in the coming period. Overall, our estimates increase from $1.10 to $1.15 for FY13 and our price target moves to $16."
For an analyst ratings summary and ratings history on NVIDIA click here. For more ratings news on NVIDIA click here.
Shares of NVIDIA closed at $14.47 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Reiterates Buy Rating on NVIDIA (NVDA)
- Deutsche Bank Downgrades Oxford Biomedica (OXB:LN) (OXBDF) to Hold
- Active options: NVDA TSLA MU SPCX AAPL AMZN MSFT META INTC
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
NomuraSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
